Mylan extends its EpiPen recall to the US and many other parts of the world
A widespread recall of EpiPen that began last week in several countries has now spread to the United States and parts of Europe, Asia, and North and South America due to a product defect.
For the moment, it remains unclear the number of allergic-reaction devices are being recalled. The effort, which Mylan described as voluntarily, began earlier this month in Australia, Denmark, Ireland, Norway, Finland, New Zealand and Japan, where tens of thousands of EpiPens were pulled.
